業聚醫療 (6929.HK)

4.330 +0.100 (+2.36%) 市場開市。 截至 11:41AM HKT。

業聚醫療

Building 20E
3rd Floor Units 303 & 305 Hong Kong Science Park
Sha Tin
Hong Kong
852 2802 2288
https://orbusneich.com

版塊: Healthcare
行業: Medical Instruments & Supplies
全職員工: 1,249

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. David Chien	Chairman of the Board & CEO	7.9M	無	1965
Mr. Wing Shing Chen	CFO, Company Secretary & Executive Director	4.44M	無	1982
Ms. Kwai Ching Lau	COO & Executive Director	5.48M	無	1975
Mr. Robert John Cottone	Chief Technical Officer	無	無	1964
Mr. Alain Djamel Khair	Chief Commercial Officer	無	無	1971

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

OrbusNeich Medical Group Holdings Limited, an investment holding company, researches, develops, manufactures, trades in, sells, and markets medical devices/instruments used for the treatment of coronary and peripheral vascular diseases in Japan, Europe, the Middle East, Africa, the Asia Pacific, the People's Republic of China, and the United States. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, stents for implantation, non-compliant balloons for post-dilatation, and specialty catheters, as well as sirolimus-eluting coronary stents, peripheral self-expandable stents, and paclitaxel-coated PTCA and PTA balloons. Its product portfolio covers various treatment processes in percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. The company was founded in 2001 and is headquartered in Sha Tin, Hong Kong. OrbusNeich Medical Group Holdings Limited is a subsidiary of Harmony Tree Limited.

公司管治

截至 無 止，業聚醫療 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。